About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- paroxetine
- Procedure number
- PSUSA/00002319/202212
- Regulatory outcome
- Variation
Documents
Paroxetine : List of nationally authorised medicinal products - PSUSA/00002319/202212
English (EN) (441.62 KB - PDF)
Paroxetine : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002319/202212
English (EN) (115.49 KB - PDF)
български (BG) (202.96 KB - PDF)
español (ES) (170.59 KB - PDF)
čeština (CS) (163.54 KB - PDF)
dansk (DA) (169.45 KB - PDF)
Deutsch (DE) (141.48 KB - PDF)
eesti keel (ET) (189.14 KB - PDF)
ελληνικά (EL) (186.3 KB - PDF)
français (FR) (134.49 KB - PDF)
hrvatski (HR) (209.37 KB - PDF)
íslenska (IS) (117.15 KB - PDF)
italiano (IT) (176.01 KB - PDF)
latviešu valoda (LV) (198.67 KB - PDF)
lietuvių kalba (LT) (196.5 KB - PDF)
magyar (HU) (132.53 KB - PDF)
Malti (MT) (198.1 KB - PDF)
Nederlands (NL) (138.6 KB - PDF)
norsk (NO) (84.36 KB - PDF)
polski (PL) (187.5 KB - PDF)
português (PT) (174.8 KB - PDF)
română (RO) (215.25 KB - PDF)
slovenčina (SK) (174.13 KB - PDF)
slovenščina (SL) (196.24 KB - PDF)
Suomi (FI) (128.02 KB - PDF)
svenska (SV) (150.5 KB - PDF)